+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID05885022

Evaluation of the Safety and Effectiveness of the Calibreye Glaucoma Implant in Adults with Open-Angle Glaucoma

Led by Myra Vision Inc. · Updated on 2025-12-15

60

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and feasibility of the Calibreye System, a glaucoma device, in patients with open-angle glaucoma. The study focuses on a surgical procedure using this implant to reduce intraocular pressure, which is important for managing this eye condition. It is a prospective, nonrandomized, open-label feasibility clinical trial sponsored by Myra Vision Inc. Participants will receive the Calibreye glaucoma device as a permanent implant. The study does not include a comparison group and will monitor the effects of the device implantation over time. The focus is on how well the device works to lower intraocular pressure and its safety during and after surgery. During the study, participants will be assessed for intraocular pressure and any adverse events for up to 12 months. Researchers will also track the use of glaucoma medications over this period. The study involves monitoring safety and effectiveness through clinical visits and evaluations, lasting up to one year from device implantation.

CONDITIONS

Brief Title

Feasibility Clinical Evaluation of the Calibreye System

Research Team

S

Shienal Patel

M

Michelle Tran

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here